IDHIFA® is an oral prescription medicine used to treat people with AML with an IDH2 mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA® is safe and effective in children.
Your doctor has determined that IDHIFA® is an appropriate treatment choice for you because you have a specific type of mutation known as IDH2. The IDH2 mutation blocks blasts from maturing into healthy adult blood cells. Approximately 8% to 19% of people with AML have this mutation. IDHIFA® is not traditional chemotherapy. It is the first and only medication in a class called IDH2 inhibitors that is specifically used for people with relapsed or refractory AML with an IDH2 mutation. The following information may help you understand your treatment with IDHIFA®.
Before taking IDHIFA®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.